Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics
Abstract Background Mitochondrial fission regulator 2 (MTFR2) was involved in the progression and development of various cancers. However, the relationship between MTFR2 with lung adenocarcinoma (LUAD) had not been reported. Herein, this study analyzed the clinical significance and potential mechani...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08378-3 |
id |
doaj-8473cd43071048558919f7d5207fa7f7 |
---|---|
record_format |
Article |
spelling |
doaj-8473cd43071048558919f7d5207fa7f72021-05-30T11:49:09ZengBMCBMC Cancer1471-24072021-05-0121111410.1186/s12885-021-08378-3Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformaticsCheng Chen0Yang Tang1Wen-Dong Qu2Xu Han3Jie-Bin Zuo4Qing-Yong Cai5Gang Xu6Yong-Xiang Song7Xi-Xian Ke8Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityDepartment of Thoracic Surgery, Affiliated Hospital of Zunyi Medical UniversityAbstract Background Mitochondrial fission regulator 2 (MTFR2) was involved in the progression and development of various cancers. However, the relationship between MTFR2 with lung adenocarcinoma (LUAD) had not been reported. Herein, this study analyzed the clinical significance and potential mechanisms of MTFR2 in LUAD via bioinformatics tools. Results We found that the level of MTFR2 was increased, and correlated with sex, age, smoking history, neoplasm staging, histological subtype and TP53 mutation status in LUAD patients. Kaplan-Meier survival analysis showed LUAD patients with increased MTFR2 had a poor prognosis. In addition, univariate COX regression analysis showed neoplasm staging, T stage, distant metastasis and MTFR2 level were risk factors for the prognosis of LUAD. A total of 1127 genes were coexpressed with MTFR2, including 840 positive and 208 negative related genes. KEGG and GSEA found that MTFR2 participated in the progression of LUAD by affecting cell cycle, DNA replication, homologous recombination, p53 signaling pathway and other mechanisms. The top 10 coexpressed genes, namely CDK1, CDC20, CCNB1, PLK1, CCNA2, AURKB, CCNB2, BUB1B, MAD2L1 and BUB1 were highly expressed, and were associated with poor prognosis in LUAD. Conclusions Consequently, we elucidated MTFR2 was a biomarker for diagnosis and poor prognosis in LUAD, and might participate in the progression of LUAD via affecting cell cycle, DNA replication, homologous recombination and p53 signaling pathway.https://doi.org/10.1186/s12885-021-08378-3Lung adenocarcinomaPrognosisMTFR2BioinformaticsBiomarker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cheng Chen Yang Tang Wen-Dong Qu Xu Han Jie-Bin Zuo Qing-Yong Cai Gang Xu Yong-Xiang Song Xi-Xian Ke |
spellingShingle |
Cheng Chen Yang Tang Wen-Dong Qu Xu Han Jie-Bin Zuo Qing-Yong Cai Gang Xu Yong-Xiang Song Xi-Xian Ke Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics BMC Cancer Lung adenocarcinoma Prognosis MTFR2 Bioinformatics Biomarker |
author_facet |
Cheng Chen Yang Tang Wen-Dong Qu Xu Han Jie-Bin Zuo Qing-Yong Cai Gang Xu Yong-Xiang Song Xi-Xian Ke |
author_sort |
Cheng Chen |
title |
Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics |
title_short |
Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics |
title_full |
Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics |
title_fullStr |
Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics |
title_full_unstemmed |
Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics |
title_sort |
evaluation of clinical value and potential mechanism of mtfr2 in lung adenocarcinoma via bioinformatics |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2021-05-01 |
description |
Abstract Background Mitochondrial fission regulator 2 (MTFR2) was involved in the progression and development of various cancers. However, the relationship between MTFR2 with lung adenocarcinoma (LUAD) had not been reported. Herein, this study analyzed the clinical significance and potential mechanisms of MTFR2 in LUAD via bioinformatics tools. Results We found that the level of MTFR2 was increased, and correlated with sex, age, smoking history, neoplasm staging, histological subtype and TP53 mutation status in LUAD patients. Kaplan-Meier survival analysis showed LUAD patients with increased MTFR2 had a poor prognosis. In addition, univariate COX regression analysis showed neoplasm staging, T stage, distant metastasis and MTFR2 level were risk factors for the prognosis of LUAD. A total of 1127 genes were coexpressed with MTFR2, including 840 positive and 208 negative related genes. KEGG and GSEA found that MTFR2 participated in the progression of LUAD by affecting cell cycle, DNA replication, homologous recombination, p53 signaling pathway and other mechanisms. The top 10 coexpressed genes, namely CDK1, CDC20, CCNB1, PLK1, CCNA2, AURKB, CCNB2, BUB1B, MAD2L1 and BUB1 were highly expressed, and were associated with poor prognosis in LUAD. Conclusions Consequently, we elucidated MTFR2 was a biomarker for diagnosis and poor prognosis in LUAD, and might participate in the progression of LUAD via affecting cell cycle, DNA replication, homologous recombination and p53 signaling pathway. |
topic |
Lung adenocarcinoma Prognosis MTFR2 Bioinformatics Biomarker |
url |
https://doi.org/10.1186/s12885-021-08378-3 |
work_keys_str_mv |
AT chengchen evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT yangtang evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT wendongqu evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT xuhan evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT jiebinzuo evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT qingyongcai evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT gangxu evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT yongxiangsong evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics AT xixianke evaluationofclinicalvalueandpotentialmechanismofmtfr2inlungadenocarcinomaviabioinformatics |
_version_ |
1721419937840365568 |